Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial.
Saved in:
| Title: | Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial. |
|---|---|
| Authors: | Ding, Yiling1 (AUTHOR), Wang, Chunping2,3 (AUTHOR), Shu, Yamin1 (AUTHOR), Wang, Jinglin4 (AUTHOR) linlinvc202@163.com, Zhang, Qilin4 (AUTHOR) qilinzhang88@163.com |
| Source: | Journal of Pharmaceutical Policy & Practice. Dec2025, Vol. 18 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 190283053 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ding%2C+Yiling%22">Ding, Yiling</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Chunping%22">Wang, Chunping</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shu%2C+Yamin%22">Shu, Yamin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Jinglin%22">Wang, Jinglin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> linlinvc202@163.com</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Qilin%22">Zhang, Qilin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> qilinzhang88@163.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Pharmaceutical+Policy+%26+Practice%22">Journal of Pharmaceutical Policy & Practice</searchLink>. Dec2025, Vol. 18 Issue 1, p1-18. 18p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190283053 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/20523211.2025.2464781 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 18 StartPage: 1 Titles: – TitleFull: Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ding, Yiling – PersonEntity: Name: NameFull: Wang, Chunping – PersonEntity: Name: NameFull: Shu, Yamin – PersonEntity: Name: NameFull: Wang, Jinglin – PersonEntity: Name: NameFull: Zhang, Qilin IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 20523211 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Journal of Pharmaceutical Policy & Practice Type: main |
| ResultId | 1 |